Creo Medical logo

CREO - Creo Medical Share Price

191p 1.0  0.5%

Last Trade - 15/07/20

Sector
Healthcare
Size
Small Cap
Market Cap £299.3m
Enterprise Value £219.0m
Revenue £13.5k
Position in Universe 642nd / 1819
Bullish
Bearish
Unlock CREO Revenue
Momentum
Relative Strength (%)
1m -6.92%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -21.8%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.013 0.53 3.26
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2019, Creo Medical Group PLC revenues increased from £0K to £13K. Net loss increased 7% to £15.9M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Administrative expenses increase of 6% to £19M (expense), Other operating income decrease of 55% to £127K (income).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for CREO
Graphical History

Revenue

CREO Revenue Unlock CREO Revenue

Net Income

CREO Net Income Unlock CREO Revenue

Normalised EPS

CREO Normalised EPS Unlock CREO Revenue

PE Ratio Range

CREO PE Ratio Range Unlock CREO Revenue

Dividend Yield Range

CREO Dividend Yield Range Unlock CREO Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
CREO EPS Forecasts Unlock CREO Revenue
Profile Summary

Creo Medical Group plc is a United Kingdom-based medical device company. The Company focuses on the field of surgical endoscopy. The Company focuses on the development and commercialization of minimally invasive surgical devices, initially in the area of gastrointestinal (GI) surgery and lung cancer. The Company has developed CROMA, which is an electrosurgical platform that can deliver microwave and bipolar radiofrequency through a single accessory port. The Company's surgical system CROMA combines bipolar radiofrequency for localized cutting and microwave energy for controlled coagulation, which provides physicians with simplified and controlled surgical solutions. The Company's pipeline portfolio of instruments is targeted at three therapeutic endoscopic specialties: lower GI; lung/bronchoscopy and upper GI.

Directors
Last Annual December 31st, 2019
Last Interim December 31st, 2019
Incorporated September 12, 2016
Public Since December 9, 2016
No. of Shareholders: n/a
No. of Employees: 71
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index FTSE Aim All Share , FTSE Aim 100 ,
Exchange London Stock Exchange (AIM)
Shares in Issue 157,520,021
Free Float (0.0%)
Eligible for
ISAs
SIPPs
CREO Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for CREO
Upcoming Events for CREO
Frequently Asked Questions for Creo Medical
What is the Creo Medical share price?

As of 15/07/20, shares in Creo Medical are trading at 191p, giving the company a market capitalisation of £299.3m. This share price information is delayed by 15 minutes.

How has the Creo Medical share price performed this year?

Shares in Creo Medical are currently trading at 191p and the price has moved by 6.19% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Creo Medical price has moved by 28.13% over the past year.

What are the analyst and broker recommendations for Creo Medical?

Of the analysts with advisory recommendations for Creo Medical, there are there are currently 0 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Creo Medical is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Creo Medical next release its financial results?

Creo Medical is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2020-12-31
What is the Creo Medical dividend yield?

Creo Medical does not currently pay a dividend.

Does Creo Medical pay a dividend?

Creo Medical does not currently pay a dividend.

When does Creo Medical next pay dividends?

Creo Medical does not currently pay a dividend.

How do I buy Creo Medical shares?

To buy shares in Creo Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Creo Medical?

Shares in Creo Medical are currently trading at 191p, giving the company a market capitalisation of £299.3m.

Where are Creo Medical shares listed? Where are Creo Medical shares listed?

Here are the trading details for Creo Medical:

Country of listing: United Kingdom
Exchange: LSE
Ticker Symbol: CREO
What kind of share is Creo Medical?

Based on an overall assessment of its quality, value and momentum, Creo Medical is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Creo Medical share price forecast 2020?

We were not able to load any forecast data for Creo Medical.

How can I tell whether the Creo Medical share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Creo Medical. Over the past six months, the relative strength of its shares against the market has been 33.15%. At the current price of 191p, shares in Creo Medical are trading at 13.24% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Creo Medical PE Ratio?

We were not able to find PE ratio data for Creo Medical.

Who are the key directors of Creo Medical?

We were unable to find the directors for Creo Medical.

Who are the major shareholders of Creo Medical?

Here are the top five shareholders of Creo Medical based on the size of their shareholding:

Canaccord Genuity Wealth Management Investment Advisor/Hedge Fund
Percentage owned: 17.46% (27.5m shares)
Baillie Gifford & Co. Investment Advisor
Percentage owned: 8.45% (13.3m shares)
Development Bank of Wales Plc Venture Capital
Percentage owned: 8.11% (12.8m shares)
Marlborough Special Situations Retail Mutual Fund
Percentage owned: 7.36% (11.6m shares)
Marlborough UK Micro Cap Growth Retail Mutual Fund
Percentage owned: 5.36% (8.44m shares)
Similar to CREO
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.